Analyst Research

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shire Plc announces FDA approval of manufacturing facility for VPRIV drug substance


Friday, 14 Feb 2014 09:00am EST 

Shire Plc:Says that the US Food & Drug Administration (FDA) has approved the production of VPRIV drug substance (velaglucerase alfa for injection) in Shire's manufacturing facility at 400 Shire Way, Lexington, Massachusetts, US.Says the facility was previously approved by the European Medicines Agency (EMA) for production of VPRIV drug substance.